{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:28:45Z","timestamp":1790882925125,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":2730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Kinderoncologisch Centrum Rotterdam"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/annonc\/mdr511","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:52:52Z","timestamp":1320281572000},"page":"1626-1632","source":"Crossref","is-referenced-by-count":17,"title":["Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"23","author":[{"given":"M.","family":"van Waas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.C.M.M.","family":"Neggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"te Winkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Beishuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr511_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/asheducation.V2007.1.285.0010285","article-title":"Diagnosis and treatment of childhood non-Hodgkin lymphoma","volume":"2007","author":"Reiter","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1093\/annonc\/mdr511_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1370209","article-title":"Glucocorticoid osteoporosis\u2014mechanisms and management","volume":"137","author":"Reid","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1093\/annonc\/mdr511_bb0020","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1210\/jc.2008-0622","article-title":"Bone mineral density, growth and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only","volume":"94","author":"van Beek","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdr511_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00043426-199805000-00009","article-title":"Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia","volume":"20","author":"Arikoski","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0030","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.bjc.6690296","article-title":"Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood","volume":"79","author":"Brennan","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr511_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3476(05)80536-0","article-title":"Osteoporosis after cranial irradiation for acute lymphoblastic leukemia","volume":"117","author":"Gilsanz","year":"1990","journal-title":"J Pediatr"},{"key":"10.1093\/annonc\/mdr511_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00043426-199611000-00006","article-title":"Bone density in survivors of childhood malignancies","volume":"18","author":"Henderson","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1096-911X(20001001)35:4<415::AID-MPO4>3.0.CO;2-9","article-title":"Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood","volume":"35","author":"van der Sluis","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0050","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1200\/JCO.2001.19.11.2970","article-title":"Bone mass after treatment for acute lymphoblastic leukemia in childhood","volume":"19","author":"Nysom","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pbc.20437","article-title":"No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia","volume":"46","author":"van Beek","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdr511_bb0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/pbc.21496","article-title":"Obesity in long-term survivors of childhood acute lymphoblastic leukemia","volume":"51","author":"Asner","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdr511_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/adc.79.2.161","article-title":"Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia","volume":"79","author":"Birkebaek","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1093\/annonc\/mdr511_bb0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/eje.1.01931","article-title":"Body composition in young adult survivors of childhood acute lymphoblastic leukaemia","volume":"153","author":"Jarfelt","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1093\/annonc\/mdr511_bb0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00043426-200110000-00007","article-title":"Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia","volume":"23","author":"Oeffinger","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/mpo.1304","article-title":"Body composition of long-term survivors of acute lymphoblastic leukaemia","volume":"38","author":"Warner","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2265.1999.00622.x","article-title":"Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity?","volume":"50","author":"Brennan","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1093\/annonc\/mdr511_bb0090","first-page":"4591","article-title":"Degree of fatness after treatment for acute lymphoblastic leukemia in childhood","volume":"84","author":"Nysom","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdr511_bb0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdp414","article-title":"Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer","volume":"21","author":"van Waas","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MPH.0b013e3181d419c3","article-title":"The metabolic syndrome in adult survivors of childhood cancer, a review","volume":"32","author":"van Waas","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2265.2008.03283.x","article-title":"Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL)","volume":"69","author":"Steffens","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1093\/annonc\/mdr511_bb0110","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.2008.20.1541","article-title":"Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2009.24.9037","article-title":"Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"28","author":"Green","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0120","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/AOG.0b013e3181f87c4b","article-title":"Reproductive outcomes for survivors of childhood cancer","volume":"116","author":"Hudson","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdr511_bb0125","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/den487","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone","volume":"24","author":"Lie Fong","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdr511_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/pbc.21780","article-title":"Effect of childhood cancer treatment on fertility markers in adult male long-term survivors","volume":"52","author":"van Casteren","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdr511_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/mpo.10260","article-title":"Degree of fatness after treatment of malignant lymphoma in childhood","volume":"40","author":"Nysom","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/pbc.20849","article-title":"Body composition and bone mass in survivors of childhood cancer","volume":"48","author":"Muszynska-Roslan","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdr511_bb0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G","article-title":"Osteopenia in young adult survivors of childhood cancer","volume":"32","author":"Vassilopoulou-Sellin","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2354.2006.00757.x","article-title":"Bone mineral status after treatment of malignant lymphoma in childhood and adolescence","volume":"16","author":"Sala","year":"2007","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1093\/annonc\/mdr511_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MPH.0b013e31818c0120","article-title":"Risk factors for the development of obesity in children surviving ALL and NHL","volume":"31","author":"Gofman","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0160","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1200\/JCO.2006.07.8709","article-title":"Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma","volume":"25","author":"Razzouk","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0165","author":"World Medical Association General Assembly","year":"2008","journal-title":"Declaration of Helsinki\u2014Sixth Revision. Helsinki, Finland"},{"key":"10.1093\/annonc\/mdr511_bb0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1203\/00006450-200003000-00006","article-title":"Continuing positive secular growth change in The Netherlands 1955\u20131997","volume":"47","author":"Fredriks","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1093\/annonc\/mdr511_bb0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00431-003-1292-x","article-title":"Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands","volume":"162","author":"Fredriks","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1093\/annonc\/mdr511_bb0180","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1651-2227.2004.tb03024.x","article-title":"Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands","volume":"93","author":"Fredriks","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1093\/annonc\/mdr511_bb0185","unstructured":"ABlokstraHASmitHBBueno de MesquitaMonitoring van Risicofactoren en Gezondheid in Nederland (MORGEN-project), 1993\u20131997Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Bilthoven, Netherlands. 1999"},{"key":"10.1093\/annonc\/mdr511_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S8756-3282(95)00162-X","article-title":"Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology","volume":"17","author":"Kr\u00f6ger","year":"1995","journal-title":"Bone"},{"key":"10.1093\/annonc\/mdr511_bb0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/adc.87.4.341","article-title":"Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults","volume":"87","author":"van der Sluis","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1093\/annonc\/mdr511_bb0200","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1515\/CCLM.2004.112","article-title":"Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)","volume":"42","author":"Elmlinger","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1093\/annonc\/mdr511_bb0205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdr511_bb0210","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/en.2005-1588","article-title":"Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice","volume":"147","author":"Kevenaar","year":"2006","journal-title":"Endocrinology"},{"key":"10.1093\/annonc\/mdr511_bb0215","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.fertnstert.2007.08.006","article-title":"Semen cryopreservation in pubertal boys before gonadotoxic treatment and the role of endocrinologic evaluation in predicting sperm yield","volume":"90","author":"van Casteren","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdr511_bb0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/07853890310004084","article-title":"Inhibin B: a novel marker of spermatogenesis","volume":"35","author":"Pierik","year":"2003","journal-title":"Ann Med"},{"key":"10.1093\/annonc\/mdr511_bb0225","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1991.9.3.400","article-title":"Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia","volume":"9","author":"Schriock","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3476(05)80948-5","article-title":"Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia","volume":"123","author":"Katz","year":"1993","journal-title":"J Pediatr"},{"key":"10.1093\/annonc\/mdr511_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-3476(05)81537-9","article-title":"Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation","volume":"123","author":"Sklar","year":"1993","journal-title":"J Pediatr"},{"key":"10.1093\/annonc\/mdr511_bb0240","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1200\/JCO.2003.03.068","article-title":"Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment","volume":"21","author":"Dalton","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr511_bb0245","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ctrv.2009.06.004","article-title":"Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review","volume":"35","author":"Mulder","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdr511_bb0250","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1515\/JPEM.2008.21.10.943","article-title":"Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy","volume":"21","author":"Bonato","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1093\/annonc\/mdr511_bb0255","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1507\/endocrj.K08E-075","article-title":"Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital","volume":"55","author":"Miyoshi","year":"2008","journal-title":"Endocr J"},{"key":"10.1093\/annonc\/mdr511_bb0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11764-007-0038-6","article-title":"Endocrine sequelae of cancer and cancer treatments","volume":"1","author":"Stava","year":"2007","journal-title":"J Cancer Surviv"},{"key":"10.1093\/annonc\/mdr511_bb0265","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbmt.2007.06.003","article-title":"Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study","volume":"13","author":"Majhail","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1093\/annonc\/mdr511_bb0270","first-page":"398","article-title":"Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients","volume":"52","author":"Lemez","year":"2005","journal-title":"Neoplasma"},{"key":"10.1093\/annonc\/mdr511_bb0275","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jcem.83.9.5121","article-title":"Serum inhibin B as a marker of spermatogenesis","volume":"83","author":"Pierik","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdr511_bb0280","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fertnstert.2006.01.022","article-title":"Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility","volume":"86","author":"Kumanov","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdr511_bb0285","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/humrep\/12.11.2376","article-title":"Inhibin B in men with normal and disturbed spermatogenesis","volume":"12","author":"Klingmuller","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdr511_bb0290","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/humrep\/dem313","article-title":"Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood","volume":"22","author":"van Beek","year":"2007","journal-title":"Hum Reprod"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938723X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938723X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/6\/1626\/403652\/mdr511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:29:19Z","timestamp":1624699759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341938723X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S092375341938723X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr511","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}